MYLAN-RIVASTIGMINE PATCH 10
Active Ingredient: RIVASTIGMINE
Product Overview
About MYLAN-RIVASTIGMINE PATCH 10
Mylan-Rivastigmine Patch 10 is a transdermal patch formulation containing the active ingredient Rivastigmine, used in the management of mild to moderate dementia of the Alzheimer's type and for the treatment of Parkinson's disease.
Key Benefits & Uses
- Slows down the progression of cognitive decline in patients with Alzheimer's disease
- Improves cognitive function in patients with mild to moderate dementia of the Alzheimer's type
- Reduces symptoms of Parkinson's disease, such as tremors and rigidity
Active Ingredient & Action
Rivastigmine, the active ingredient in Mylan-Rivastigmine Patch 10, is a cholinesterase inhibitor that works by increasing the concentration of acetylcholine in the brain, a neurotransmitter that plays a key role in memory and cognitive function. By inhibiting the breakdown of acetylcholine, Rivastigmine helps to improve cognitive function and slow down the progression of cognitive decline in patients with Alzheimer's disease.
Important Notes
It is essential to follow the recommended dosage and application instructions provided by your healthcare professional. The patch should be applied to a clean, dry area of skin, and the area should be avoided for at least 14 days after removal of the patch. Common side effects may include skin irritation, nausea, and vomiting. If you experience any severe side effects or have concerns, consult your healthcare professional immediately.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
